Valued at approximately USD 15 billion in 2023, the market is projected to expand at a compound annual growth rate (CAGR) of around 20% from 2024 to 2032, reaching an estimated USD 85 billion by 2032. This upward trajectory is fueled by technological advancements and the growing demand for personalized medicine.